Insilico’s Potential Best-in-Class AI Drug for Sought-After Cancer Target
What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat…
Continue Reading